Simon E. Koele

Also affiliated with University Medical Center, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Amalia Kinderziekenhuis

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A 3-month clofazimine–rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial”.

A 3-month clofazimine–rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00436-0

N/A

0.315DataRank · unranked

4 citations

Isabelle R. Weir, Kimberly K. Scarsi, Alberto Mendoza‐Ticona, Samuel Pierre, Luke Hall +30 more

Optimized Loading Dose Strategies for Bedaquiline When Restarting Interrupted Drug-Resistant Tuberculosis Treatment

Antimicrobial Agents and Chemotherapy(2022)10.1128/aac.01749-21

N/A

0DataRank · unranked

3 citations

Stijn W. van Beek, Gary Maartens, James C. M. Brust, Elin M. Svensson, Simon E. Koele